{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:25:51Z","timestamp":1791116751786,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T00:00:00Z","timestamp":1190937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s10571-007-9220-7","type":"journal-article","created":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T18:34:40Z","timestamp":1190918080000},"page":"1127-1145","source":"Crossref","is-referenced-by-count":31,"title":["Increased Caspase-2, Calpain Activations and Decreased Mitochondrial Complex II Activity in Cells Expressing Exogenous Huntingtin Exon 1 Containing CAG Repeat in the Pathogenic Range"],"prefix":"10.1007","volume":"27","author":[{"given":"Pritha","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swasti","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswanath","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitai P.","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,28]]},"reference":[{"key":"9220_CR1","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Deglon N, Brouillet E (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 17:1652\u20131663","journal-title":"Mol Biol Cell"},{"key":"9220_CR2","doi-asserted-by":"crossref","first-page":"43245","DOI":"10.1074\/jbc.M305057200","volume":"278","author":"N Bizat","year":"2003","unstructured":"Bizat N, Hermel JM, Humbert S, Jacquard C, Creminon C, Escartin C, Saudou F, Krajewski S, Hantraye P, Brouillet E (2003) In\u00a0vivo calpain\/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3. J Biol Chem 278:43245\u201343253","journal-title":"J Biol Chem"},{"key":"9220_CR3","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","volume":"44","author":"WA Brennan Jr","year":"1985","unstructured":"Brennan WA Jr, Bird ED, Aprille JR (1985) Regional mitochondrial respiratory activity in Huntington\u2019s disease brain. J Neurochem 44:1948\u20131950","journal-title":"J Neurochem"},{"key":"9220_CR4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653","journal-title":"Ann Neurol"},{"key":"9220_CR5","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"9220_CR6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha J, Friedlander RM (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797\u2013801","journal-title":"Nat Med"},{"key":"9220_CR7","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0600554103","volume":"103","author":"CA Conrad","year":"2006","unstructured":"Conrad CA, Tiina MK, Andreu VV, Raymond AS (2006) Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentration. Proc Natl Acad Sci USA 103:9685\u20139690","journal-title":"Proc Natl Acad Sci USA"},{"key":"9220_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","volume":"75","author":"CM Cowan","year":"2006","unstructured":"Cowan CM, Raymond LA (2006) Selective neuronal degeneration in Huntington\u2019s disease. Curr Top Dev Biol 75:25\u201371","journal-title":"Curr Top Dev Biol"},{"key":"9220_CR9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00001756-199505090-00026","volume":"6","author":"M Dragunow","year":"1995","unstructured":"Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E (1995) In\u00a0situ evidence for DNA fragmentation in Huntington\u2019s disease striatum and Alzheimer\u2019s disease temporal lobes. Neuroreport 6:1053\u20131057","journal-title":"Neuroreport"},{"key":"9220_CR10","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1128\/MCB.25.13.5389-5395.2005","volume":"25","author":"L Feng","year":"2005","unstructured":"Feng L, Lin T, Uranishi H, Gu W, Xu Y (2005) Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol 25:5389\u20135395","journal-title":"Mol Cell Biol"},{"key":"9220_CR11","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni J, Ellerby LM (2002) Calpain activation in Huntington\u2019s disease. J Neurosci 22:4842\u20134849","journal-title":"J Neurosci"},{"key":"9220_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncb735","volume":"4","author":"FG Gervais","year":"2002","unstructured":"Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst CA, Leavitt BR, Metzler M, Hackam AS, Tam J, Vaillancourt JP, Houtzager V, Rasper DM, Roy S, Hayden MR, Nicholson DW (2002) Recruitment and activation of caspase-8 bythe Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 4:95\u2013105","journal-title":"Nat Cell Biol"},{"key":"9220_CR13","doi-asserted-by":"crossref","first-page":"39594","DOI":"10.1074\/jbc.C200353200","volume":"277","author":"D Goffredo","year":"2002","unstructured":"Goffredo D, Rigamonti D, Tartari M, De-Micheli A, Verderio C, Matteoli M, Zuccato C, Cattaneo E (2002) Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J Biol Chem 277:39594\u201339598","journal-title":"J Biol Chem"},{"key":"9220_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mcn.2005.12.004","volume":"31","author":"GT Gomez","year":"2006","unstructured":"Gomez GT, Hu H, McCaw EA, Denovan-Wright EM (2006) Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation. Mol Cell Neurosci 31:661\u2013675","journal-title":"Mol Cell Neurosci"},{"key":"9220_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389","journal-title":"Ann Neurol"},{"key":"9220_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/mcne.2002.1136","volume":"20","author":"C Guegan","year":"2002","unstructured":"Guegan C, Vila M, Teismann P, Chen C, Onteniente B, Li M, Friedlander RM, Przedborski S (2002) Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS. Mol Cell Neurosci 20:553\u2013562","journal-title":"Mol Cell Neurosci"},{"key":"9220_CR17","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1074\/jbc.C100025200","volume":"276","author":"S Gupta","year":"2001","unstructured":"Gupta S, Radha V, Furukawa Y, Swarup G (2001) Direct transcriptional activation of human caspase1 by tumor suppressor p53, J. Biol Chem 276:10585\u2013105858","journal-title":"Biol Chem"},{"key":"9220_CR18","doi-asserted-by":"crossref","first-page":"41299","DOI":"10.1074\/jbc.M008408200","volume":"275","author":"AS Hackam","year":"2000","unstructured":"Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst C-A, Gan L, Warby S, Wellington CL, Vaillancourt J, Chen N, Gervais FG, Raymond L, Nicholson DW, Hayden MR (2000) Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem 275:41299\u201341308","journal-title":"J Biol Chem"},{"key":"9220_CR19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","volume":"11","author":"E Hermel","year":"2004","unstructured":"Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS, Logvinova AV, Peel AL, Chen SF, Hook V, Singaraja R, Krajewski S, Goldsmith PC, Ellerby HM, Hayden MR, Bredesen DE, Ellerby LM (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington\u2019s disease. Cell Death Differ 11:424\u2013438","journal-title":"Cell Death Differ"},{"key":"9220_CR20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.38.7.450","volume":"38","author":"LW Ho","year":"2001","unstructured":"Ho LW, Brown R, Maxwell M, Wyttenbach A, Rubinsztein DC (2001) Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington\u2019s disease. J Med Genet 38:450\u2013452","journal-title":"J Med Genet"},{"key":"9220_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neuro degeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"9220_CR22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","volume":"19","author":"M Kim","year":"1999","unstructured":"Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P, Kim. TW, Williams M, Reddy PH, Tagle D, Boyce FM, Won L, Heller A, Aronin N, DiFiglia M (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 19:964\u2013973","journal-title":"J Neurosci"},{"key":"9220_CR23","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/hmg\/9.19.2859","volume":"9","author":"SH Li","year":"2000","unstructured":"Li SH, Lam S, Cheng AL, Li XJ (2000) Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis. Hum Mol Genet 9:2859\u20132867","journal-title":"Hum Mol Genet"},{"key":"9220_CR24","first-page":"881","volume":"35","author":"CX Lu","year":"2003","unstructured":"Lu CX, Fan TJ, Hu GB, Cong RS (2003) Apoptosis-inducing factor and apoptosis. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35:881\u2013885","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"key":"9220_CR25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2005.11.003","volume":"22","author":"P Majumder","year":"2006","unstructured":"Majumder P, Chattopadhyay B, Mazumder A, Das P, Bhattacharyya NP (2006) Induction of apoptosis in cells expressing exogenous Hippi, a molecular partner of huntingtin-interacting protein HIP1. Neurobiol Dis 22:242\u2013256","journal-title":"Neurobiol Dis"},{"key":"9220_CR26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","volume":"336","author":"VM Mann","year":"1990","unstructured":"Mann VM, Cooper JM, Javoy-Agid F, Agid Y, Jenner P, Schapira AH (1990) Mitochondrial function and parental sex effect in Huntington\u2019s disease. Lancet 336:749","journal-title":"Lancet"},{"key":"9220_CR27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jmg.36.10.739","volume":"36","author":"Y Narain","year":"1999","unstructured":"Narain Y, Wyttenbach A, Rankin J, Furlong RA, Rubinsztein DC (1999) A molecular investigation of true dominance in Huntington\u2019s disease. J Med Genet 36:739\u2013746","journal-title":"J Med Genet"},{"key":"9220_CR28","doi-asserted-by":"crossref","unstructured":"Nenguke T, Aladjem MI, Gusella JF, Wexler NS, The Venezuela HD Project, Arnheim N (2003) Candidate DNA replication initiation regions at human trinucleotide repeat disease loci. Hum Mol Genet 12:1021\u20131028","DOI":"10.1093\/hmg\/ddg111"},{"key":"9220_CR29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbrc.2005.10.061","volume":"338","author":"K Omi","year":"2005","unstructured":"Omi K, Hachiya NS, Tokunaga K, Kaneko K (2005) siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in\u00a0vitro. Biochem Biophys Res Commun 338:1229\u20131235","journal-title":"Biochem Biophys Res Commun"},{"key":"9220_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE, Yuan J, Penney JB, Young AB, Cha JH, Friedlander RM (1999) Inhibition of caspase1 slows disease progression in a mouse model of Huntington\u2019s disease. Nature 399:263\u2013267","journal-title":"Nature"},{"key":"9220_CR31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2006.01.007","volume":"341","author":"KL Puranam","year":"2006","unstructured":"Puranam KL, Wu G, Strittmatter WJ, Burke JR (2006) Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria. Biochem Biophys Res Commun 341:607\u2013613","journal-title":"Biochem Biophys Res Commun"},{"key":"9220_CR32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1083\/jcb.200209004","volume":"159","author":"SH Read","year":"2002","unstructured":"Read SH, Baliga BC, Ekert PG, Vaux DL, Kumar S (2002) A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol 159:739\u2013745","journal-title":"J Cell Biol"},{"key":"9220_CR33","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1074\/jbc.C100044200","volume":"276","author":"D Rigamonti","year":"2001","unstructured":"Rigamonti D, Sipione S, Goffredo D, Zuccato C, Fossale E, Cattaneo E (2001) Huntingtin\u2019s neuroprotective activity occurs via inhibition of procaspase-9 processing. J Biol Chem 276:14545\u201314548","journal-title":"J Biol Chem"},{"key":"9220_CR34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/hmg\/ddh082","volume":"13","author":"Q Ruan","year":"2004","unstructured":"Ruan Q, Lesort M, MacDonald ME, Johnson GV (2004) Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Hum Mol Genet 13:669\u2013681","journal-title":"Hum Mol Genet"},{"key":"9220_CR35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80716-3","volume":"22","author":"I Sanchez","year":"1999","unstructured":"Sanchez I, Xu CJ, Juo P, Kakizaka A, Biens J, Yuan J (1999) Caspase 8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22:623\u2013633","journal-title":"Neuron"},{"key":"9220_CR36","first-page":"25","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter M, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Neurol 45:25\u201332","journal-title":"Neurol"},{"key":"9220_CR37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(95)90541-3","volume":"81","author":"M Tewari","year":"1995","unstructured":"Tewari M, Quan LT, O\u2019Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM (1995) Yama\/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801\u2013809","journal-title":"Cell"},{"key":"9220_CR38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9220_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/exnr.1995.1029","volume":"133","author":"LB Thomas","year":"1995","unstructured":"Thomas LB, Gates DJ, Richfield EK, O\u2019Brien TF, Schweitzer JB, Steindler DA (1995) DNA end labeling (TUNEL) in Huntington\u2019s disease and other neuropathological conditions. Exp Neurol 133:265\u2013272","journal-title":"Exp Neurol"},{"key":"9220_CR40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbamcr.2005.01.001","volume":"1743","author":"T Vaisid","year":"2005","unstructured":"Vaisid T, Kosower NS, Barnoy S (2005) Caspase-1 activity is required for neuronal differentiation of PC12 cells: cross-talk between the caspase and calpain systems. Biochim Biophys Acta 1743:223\u2013230","journal-title":"Biochim Biophys Acta"},{"key":"9220_CR41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","volume":"109","author":"JC Vis","year":"2005","unstructured":"Vis JC, Schipper E, de Boer-van HRT, Verbeek MM, de Waal RM, Wesseling P, ten Donkelaar HJ, Kremer B (2005) Expression pattern of apoptosis-related markers in Huntington\u2019s disease. Acta Neuropathol (Berl) 109:321\u2013328","journal-title":"Acta Neuropathol (Berl)"},{"key":"9220_CR42","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/00001756-199908200-00001","volume":"10","author":"GH Wang","year":"1999","unstructured":"Wang GH, Mitsui K, Kotliarova S, Yamashita A, Nagao Y, Tokuhiro S, Iwatsubo T, Kanazawa I, Nukina N (1999) Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. Neuroreport 10:2435\u20132438","journal-title":"Neuroreport"},{"key":"9220_CR44","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","volume":"100","author":"X Wang","year":"2003","unstructured":"Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease. Proc Nat Acad Sci USA 100:10483\u201310487","journal-title":"Proc Nat Acad Sci USA"},{"key":"9220_CR43","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1523\/JNEUROSCI.4181-05.2005","volume":"25","author":"X Wang","year":"2005","unstructured":"Wang X, Wang H, Figueroa BE, Zhang WH, Huo C, Guan Y, Zhang Y, Bruey JM, Reed JC, Friedlander RM (2005) Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington\u2019s disease. J Neurosci 25:11645\u201311654","journal-title":"J Neurosci"},{"key":"9220_CR45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nbd.2004.07.021","volume":"17","author":"L Yang","year":"2004","unstructured":"Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF (2004) A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in\u00a0vivo. Neurobiol Dis 17:250\u2013259","journal-title":"Neurobiol Dis"},{"key":"9220_CR46","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00001756-200308060-00006","volume":"14","author":"EA Zemskov","year":"2003","unstructured":"Zemskov EA, Nukina N (2003) Impaired degradation of PKCalpha by proteasome in a cellular model of Huntington\u2019s disease. Neuroreport 14:1435\u20131438","journal-title":"Neuroreport"},{"key":"9220_CR47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.2003.02105.x","volume":"87","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Ona VO, Li M, Drozda M, Dubois-Dauphin M, Przedborski S, Ferrante RJ, Friedlander RM (2003) Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington\u2019s disease. J Neurochem 87:1184\u20131192","journal-title":"J Neurochem"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-007-9220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-007-9220-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-007-9220-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:06:28Z","timestamp":1559239588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-007-9220-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,28]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["9220"],"URL":"https:\/\/doi.org\/10.1007\/s10571-007-9220-7","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,28]]}}}